Filter
2252
Filtered Results: 2252
Text search:
drug
interactions
Featured
Recommendations
221
New Publications
540
Language
Document type
No document type
1434
Studies & Reports
290
Guidelines
285
Manuals
103
Strategic & Response Plan
55
Training Material
41
Fact sheets
32
Situation Updates
8
Resource Platforms
2
Infographics
2
Countries / Regions
India
129
Global
75
Kenya
72
South Africa
62
Ethiopia
49
Western and Central Europe
48
Nigeria
45
Nepal
43
Uganda
41
Tanzania
40
Sierra Leone
35
Malawi
35
Latin America and the Carribbean
33
Liberia
31
Zambia
29
Ghana
27
Bangladesh
27
Africa
25
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Cambodia
16
Russia
16
Lesotho
15
Philippines
15
Botswana
15
South–East Asia Region
14
Zimbabwe
12
Asia
11
Congo, Democratic Republic of
11
Eswatini/ Swaziland
9
Syria
8
Mozambique
8
USA
8
Eastern Europe and Central Asia
7
Indonesia
7
Germany
6
West and Central Africa
6
Middle East and North Africa
6
Tajikistan
5
Brazil
5
South Sudan
5
Thailand
4
Afghanistan
4
Haiti
4
North America
4
East and Southern Africa
4
Georgia
4
Pakistan
4
Chile
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Guinea
3
Western Pacific Region
3
United Kingdom
3
Vietnam
3
North Macedonia
2
Colombia
2
Kazakhstan
2
Kyrgyzstan
2
Peru
2
Armenia
2
Argentina
2
Sri Lanka
2
Sudan
2
Yemen
2
Iraq
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Gambia
1
China
1
Iran
1
Canada
1
Senegal
1
Estonia
1
Austria
1
Qatar
1
Venezuela
1
Ireland
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Southern Africa
1
Bolivia
1
Papua New Guinea
1
Palestine
1
Libya
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
770
Clinical Guidelines
237
Public Health
138
Women & Child Health
70
Key Resources
53
Capacity Building
47
Pharmacy & Technologies
11
Toolboxes
Mental Health
327
HIV
260
TB
230
COVID-19
97
AMR
88
NTDs
78
Pharmacy
62
NCDs
50
Caregiver
44
Disability
39
Planetary Health
37
Ebola & Marburg
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
8
Malaria
7
Cholera
6
Natural Hazards
5
Zika
2
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
This document is to support local authorities, leaders and policy-makers in cities and other urban settlements in identifying effective approaches and implementing recommended actions that enhance the prevention, preparedness and readiness for COVID-19 in urban settings, to ensure a robust response ...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO guidance. The m...
Stories of how people in Georgia, Laos, Sri Lanka, Tajikistan and Vietnam made inclusive development happen in their societies. It contains significant experiences andlessons learnt about the practice of inclusive development for a wide range of excluded or marginalised groups, useful for policy-mak...
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This document adopts a health determinants framework for examining the evidence related to women’s poor mental health. From this perspective, public policy including economic policy, socio-cultural and environmental factors, community and social support, stressors and life events, personal behavio...
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO ...
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Med Princ Pract 2021;30:17–28
An overview of ethics and clinical ethics is presented in this review. The 4 main ethical principles, that is beneficence, nonmaleficence, autonomy, and justice, are defined and explained. Informed consent, truth-telling, and confidentiality spring from the ...
16.7.2021
Participant Modules
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
